Skip to main content
Premium Trial:

Request an Annual Quote

IncellDx Gains ISO Certification

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Silicon Valley molecular diagnostics firm IncellDx today said that it has achieved ISO 13485:2003 and ISO 9001:2008 certification.

Both certifications came with no deficiencies, the company said.

Based in Menlo Park, Calif., IncellDx's lead technology, called simultaneous ultrasensitive subpopulation staining/hybridization in situ, or SUSHI, is a method for getting the company's reagents into a cell in order to amplify signals. In January, the company announced it had raised $3 million in a Series A financing round to fund a clinical trial for its human papillomavirus test.

IncellDx today said that it will run clinical trials on the test this year followed by an application for FDA clearance.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.